EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Preoperative topical nepafenac and vitreous inflammatory biomarkers in early proliferative vitreoretinopathy: a randomized controlled trial

Ari Djatikusumo, Andi Arus Victor, Rina La Distia Nora, Heri Wibowo, Seruni Hanna Ardhia

Journal of Retina-Vitreous · 2026 · 35 (2) · 145

DOI: 10.37845/ret.vit.2026.35.19 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Retina-Vitreous, 2026. Verfasst von Ari Djatikusumo und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Djatikusumo, A., Victor, A. A., Nora, R. L. D., Wibowo, H., & Ardhia, S. H. (2026). Preoperative topical nepafenac and vitreous inflammatory biomarkers in early proliferative vitreoretinopathy: a randomized controlled trial. Journal of Retina-Vitreous, 35(2), 145. https://doi.org/10.37845/ret.vit.2026.35.19

Vancouver

Djatikusumo A, Victor AA, Nora RLD, Wibowo H, Ardhia SH. Preoperative topical nepafenac and vitreous inflammatory biomarkers in early proliferative vitreoretinopathy: a randomized controlled trial. Journal of Retina-Vitreous. 2026;35(2):145. doi:10.37845/ret.vit.2026.35.19

BibTeX
@article{Djatikusumo2026,
  author = {Djatikusumo, Ari and Victor, Andi Arus and Nora, Rina La Distia and Wibowo, Heri and Ardhia, Seruni Hanna},
  title = {Preoperative topical nepafenac and vitreous inflammatory biomarkers in early proliferative vitreoretinopathy: a randomized controlled trial},
  journal = {Journal of Retina-Vitreous},
  year = {2026},
  volume = {35},
  number = {2},
  pages = {145},
  doi = {10.37845/ret.vit.2026.35.19}
}
Kostenlos starten →